Effects of catecholaminergic drugs upon memory storage processes in mice.
D015082:2,2'-Dipyridyl / Q000494:pharmacology; D000818:Animals; D001596:Benzylamines / Q000494:pharmacology; D001923:Brain Chemistry / Q000187:drug effects*; D002395:Catecholamines / Q000032:analysis / Q000037:antagonists & inhibitors / Q000378:metabolism*; D004050:Ditiocarb / Q000008:administration & dosage / Q000494:pharmacology; D004299:Dopamine beta-Hydroxylase / Q000037:antagonists & inhibitors*; D005669:Fusaric Acid / Q000494:pharmacology; D006220:Haloperidol / Q000494:pharmacology; D006624:Hippocampus / Q000378:metabolism; D008297:Male; D008568:Memory / Q000187:drug effects*; D008781:Methyltyrosines / Q000494:pharmacology; D051379:Mice; D010643:Phenoxybenzamine / Q000494:pharmacology; D011433:Propranolol / Q000494:pharmacology; D011807:Quinolizines / Q000494:pharmacology; D012110:Reserpine / Q000494:pharmacology; D013890:Thiourea / Q000494:pharmacology; D014446:Tyrosine 3-Monooxygenase / Q000037:antagonists & inhibitors*; D015032:Zinc / Q000378:metabolism
D001596:Benzylamines; D002395:Catecholamines; D008781:Methyltyrosines; D011807:Quinolizines; D010643:Phenoxybenzamine; D015082:2,2'-Dipyridyl; D012110:Reserpine; D004050:Ditiocarb; D011433:Propranolol; D014446:Tyrosine 3-Monooxygenase; D004299:Dopamine beta-Hydroxylase; D013890:Thiourea; D015032:Zinc; D006220:Haloperidol; D005669:Fusaric Acid